Traditional Chinese medicines in the treatment of hepatocellular cancers: A systematic review and meta-analysis

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Wu, Ping ^a   Dugoua, Jean Jacques ^b   Eyawo, Oghenowede ^c,d   Mills, Edward J ^b  

^a Tongji University   (China)

^b UNIVERSITY OF TORONTO   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRAGALUS EXTRACT; ATRACTYLODES EXTRACT; BEETLE EXTRACT; BUFOTOXIN; BUPLEURUM ROOT EXTRACT; CURCUMA LONGA EXTRACT; GINSENG EXTRACT; NATURAL PRODUCT; UNCLASSIFIED DRUG; HERBACEOUS AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BEETLE; CANCER GROWTH; CANCER SURVIVAL; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GINSENG; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; MYLABRIS PHALERATAIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT RESPONSE; CHINA; LIVER TUMOR; MULTIMODALITY CANCER THERAPY; PHYTOTHERAPY; REVIEW;

CARCINOMA, HEPATOCELLULAR; CHINA; COMBINED MODALITY THERAPY; DRUGS, CHINESE HERBAL; HUMANS; LIVER NEOPLASMS; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY;

EID: 70349139326     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-112     Document Type: Article

References (80)

1. Primary liver cancer: worldwide incidence and trends. FX Bosch J Ribes M Díaz R Cléries, Gastroenterology 2004 127 S5 S16 10.1053/j.gastro.2004.09.011 15508102 (Pubitemid 39423365)
2. World Health Organization Mortality database. http://www.who.int/whosis/ en/
3. American Cancer Scociety: Cancer Facts and Figures. http://www.cancer. org/downloads/STT/500809web.pdf
4. Diagnosis of hepatocellular carcinoma. AI Gomaa SA Khan ELS Leen I Waked SD Taylor-Robinson, World J Gastroenterol 2009 15 1301 1314 10.3748/wjg.15.1301 19294759
5. Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. P Parikh H Malhotra S Jelic Group. EGW, Ann Oncol 2008 19 27 28 10.1093/annonc/mdn114
6. Combination of log relative risk in retrospective studies of disease. PR Sheehe, Am J Public Health Nations Health 1966 56 1745 1750 5951494
7. The statistical basis of meta-analysis. JL Fleiss, Stat Methods Med Res 1993 2 121 145 10.1177/096228029300200202 8261254
8. Quantifying heterogeneity in a meta-analysis. JP Higgins SG Thompson, Stat Med 2002 21 1539 1558 10.1002/sim.1186 12111919 (Pubitemid 34746062)
9. A clinical analysis on the therapeutic effect of integrative medicine therapy on primary middle and advanced stage cancer treatment. GD Bai ZP Liang JP Huang EC Hou, Jiangsu Journal of Traditional Chinese Medicine 2008 40 8 27 29
10. Clinical Observation of Ganfukang capsule combined with TACE in primary liver cancer treatment. GW Cao XC Wang FL Zhang HF Ning YQ Sun LF Yan, Shandong Medical Journal 2005 45 2 13 14
11. Clinical study of Ai Di injection combined with transcatheter arterial chemoembolization in treatment of middle and advanced stage liver cancer. MR Cao HL Tang, Chinese Journal of Integrative Medicine 2003 23 9 713 714
12. Hepatic artery lipiodol infusion chemotherapy combined with Pei Yuan Gu Ben Kang Ai capsule in the treatment of 42 cases of mid- and late-stage hepatocellular carcinoma. C Chen JG Zhou HC Huang SH Ruan QS Zhang, Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases 2001 11 3 183 184
13. TCM combined with interventional therapy in 35 cases of primary liver cancer. J Feng, Journal of Guangxi Traditional Chinese Medical University 2002 151 13 51 52
14. Jew Ear Parasitized Granula combined with TACE on Hepatocellular Carcinoma. TS Guo FX Huang XL Cao, Chinese Journals of Practical Medicine 2005 21 16 1846 1847
15. Effects of kanglaite capsules combined with transcatheter arterial chemoembolization (TACE) on patients with mid or late-stage primary hepatocellular carcinoma (HCC). DJ Li X Xu D Bao F Xue DL Dai, Chinese-German Journal of Clinical Oncology 2009 8 2 65 68 10.1007/s10330-008-0142-8
16. Chinese herbal compound combined with TACE in primary liver cancer treatment. M Li, Clinical Research 2007 3 31 40 41
17. Clinical Study on the Treatment of Primary Liver Cancer by Cinobufotain Combined with Transcatheter Arterial Chemoembolization. Q Li BM Sun YH Peng ZZ Fan S Jue, ACTA UNIVERSITATIS TRADITIONIS MEDICALIS SINENSIS PHARMACOLOGIAEQUE SHANGHAI 2008 22 2 32 34
18. Qining injection combined with Interventional therapy in liver cancer treatment. QM Li YL Zhao, Journal of Cancer Control and Treatment 2003 16 3 160 161
19. Clinical Observation of Ai Di Injection combined with transarterial chemembolization in primary liver treatment. RP Li, Central Plains Medical Journal 2005 32 24 69
20. Clinical observation of Injectio Cinobu Facini combined with TACE on middle and advanced stage liver cancer. YJ Li XP Wang J Liu, World Clinical Drugs 2006 27 5 304 306
21. Fuzhen detoxification decoction combined with TACE in primary liver cancer treatment. J Lin, Hubei Journal of Traditional Chinese Medicine 2008 20 2 30 31
22. Analysis on the Prognostic Factors in Patients with Large Hepatocarcinoma Treated by Shentao Ruangan Pill and Hydroxycamptothecine. ZD Lin K Liu, Chinese Journal of Integrative Medicine 2005 25 1 8 11
23. Clinical Observation of Yan Shu in liver cancer treatment. XL Liu XQ Zhu, Journal of Ningxia Medical College 2002 24 2 105 106
24. Clinical Study of Aidi Injection Combined with Transcather Hepatic Arterial Chemoembolization in the Treatment of Primary Liver Cancer. GH Xiao, Cancer Research on Prevention and Treatment 2005 32 5 313 314
25. Clinical Study of TCM combined with Interventional therapy in Liver cancer Treatment. HQ Tian GW Liang Y Tao ZQ Huang SY Yu WY Ye, Journal of Henan college of Traditional Chinese Medicine 2001 16 1 47 48
26. Ai Yi Shu injection combined with chemoembolization on middle and advanced stage liver cancer. XY Tian, Central Plains Medical Journal 2006 33 6 32 34
27. Clinical Observation on Effect of Comprehensive Immunotherapy in Treating Hepatic Carcinoma after Embolism Chemotherapy. HZ Wang, Chinese Journal of Integrative Medicine 1998 18 7 411 413
28. Effectiveness evaluation of TACE combined with Ai Di injection on middle and advanced stage liver cancer treatment. QP Wang ZY Shi ZG Jiang XY Guo, Clinical Focus 2006 21 8 580 581
29. Clinical observation on treatment of primary liver cancer with ganji granule combined with tace. YC Wang, Journal OF Anhui TCM Coll Ege 2002 21 6 9 11
30. Effect on immune function in patient with primary liver cancer treated with Qing Gan Hua Yu liquid treatment. YZ Wang SK Yao LM Gao ZG Li TS Gao, Chinese Journal of Gerontology 2008 28 770 771
31. Fu Zheng Hua Ji Jie Du Fang and hepatic artery infusion chemotherapy in treatment of primary hepatocellular carcinoma. ZX Wang XH Wu SQ Chen, Henan Traditional Chinese Medicine 2001 21 6 48 49
32. Traditional-western Combined Treatment on on middle and advanced stage liver cancer, analysis of 32 cases. PY Wen Han Yin, Shan Xi TCM 2006 27 1 26 28
33. Internal and External Medicine combined with TACE in primary cancer treatment. Wen Hen Jia Zhen ZP Qu Lu Jun, Journal of Sichuan of Traditional Chinese Medicine 2008 26 4 59 60
34. Observation of long-term effectiveness of Yi Guan Jian Jia Wei combined with TACE in the treatment of hepatocellular carcinoma. JX Wu, Zhejiang Journal of Integrated Traditional Chinese and Western Medicine 1999 9 2 100 101
35. Pingxiao capsule combined with Transcather Hepatic Arterial Chemoembolization in 25 cases of Primary Liver Cancer Treatment. WG Wu WJ Guo JH Lin, Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases 2001 11 1 50 51
36. Observation of Hu Gan Ruan Jian Fang in increasing effectiveness and reducing toxicity of hepatic artery chemoembolization in stage II and II hepatocellular carcinoma. JX Wu Xiao-dong YD Wang SM Liu, Journal of Beijing University of TCM 2003 26 1 67 68
37. Clinical study of De lisheng injection combined with transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma. XJ Xing De-bing Wang Dong Wang Ge ZY Zhong ZP Li, Modern Oncology 2006 14 7 861 862
38. Appl ication of Modified Six Nobles Decoction in In tervention Therapy of Primary Liver Cancer. ZW Xu RY Zhou, Zhejiang Journal of Integrated Traditional Chinese and Western Medicine 2000 10 12 712 713
39. Transcatheter Hepatic Arter ial Chemoembolization and Aidi Injection in Treanment of Hepatocellular Carcinoma. JM Yang, Journal of Medical Forum 2006 127 120 26 27
40. Clinical observationon the effect of Kang'a i injection combined with transcatheter arterial chemoembolization on hepatocellular carcinoma in 36 patients. JZ Yi YC Xie XH Deng, Tumor 2008 28 11 997 1000
41. Injectio Cinobu Facini combined with TACE on middle and advanced stage liver cancer. MZ Yu, Journal of Guangxi Traditional Chinese Medical University 2004 171 13 35 37
42. Observation on the long-term efficacy of Qingganjiedusanjie decoction combined with interventional therapy for primary liver cancer. Zhang Ling SZ Cui CL Liu WP Chen ZY Huang, Chinese Journal of Primary Medicine and Pharmacy 2005 12 8 1010 1011
43. Clinical study of combination therapy of Jinlong capsule and chemical therapy and embolization by hepatic artery catheterization on primary hepatic carcinoma. CQ Zhang Cai-qing TJ Liang MB Yu, Beijing Medical Journal 2005 27 6 357 359
44. Clinical study of hepatic artery infusion chemotherapy combined with AC-III injection in the treatment of hepatocellular carcinoma. SY Zhang NY Geng YE Liu W Jiang WF Jiang, Information on Traditional Chinese Medicine 1996 4 29 31
45. Shanxian Granula combined with interventional therapy in liver cancer treatment. YM Zhang YX Peng HZ Guan, Journal of Shaanxi College of Traditional Chinese Medicine 2005 28 3 31 32
46. TCM combined with TACE on middle and advanced stage liver cancer treatment. JZ Zhang Yu-fang QY Mi PW Li, Chinese Journal of Surgery of Integrated Traditional and Western Medicine 2000 6 3 179 180
47. Clinical experience of TCM combined with TACE in primary cancer treatment. YQ Zhang, Journal Of New Medicine 2008 5 4 601 602
48. Short-term efficacy observation of Jew Ear Parasitized Granula combined with interventional therapy in primary liver cancer treatment. HR Zhao NS Mai BX Yong, Xinjiang Journal of Traditional Chinese Medicine 2004 22 5 27 28
49. Shen Qi capsule combined with interventional therapy in Hepatocellular Carcinoma. HK Zhao, Acta Chinese Medicine and Pharmacology 2005 133 13 28 29
50. To Treat Advanced stage liver cancer with Pinxiao capsule combined with hepatic transcatheter artery chemoembolization. BG Zhou YN Huang SH Jing WC Li, Shaanxi Oncology Medicine 1999 7 3 159 161
51. Observation of combined Chinese and Western medicine in the treatment of 26 cases of mid- and late-stage hepatocellular carcinoma. BG Zhou JZ Sun SH Jing YZ Fan H Yun-ning, Journal of New Chinese Medicine 2002 34 11 37 38
52. Effects of huachan-shu injection combind with transcatheter arterial chemoembolization on patients with advanced unresectable hepatocelluler carcinoma. JS Zhou H Lu XD Wu X Xu, Chinese Journal of Primary Medicine and Pharmacy 2006 13 4 571 572
53. The Clinical Observation of the Effect of Kanlaite Injection Combined with Chemoembolization Primary on Middle and Advanced Stage Liver Cancer. XF Zhu, Journal of Basic and Clinical Oncology 2006 119 12 132 134
54. Analysis on the Prognostic Factors in Patients with Large Hepatocarcinoma Treated by Shentao Ruangan Pill and Hydroxycamptothecine. YZ Lin DH Zhou K Liu, Chinese Journal of Integrative Medicine 2005 25 1 8 11
55. Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo. DT Chu WL Wong GM Mavligit, J Clin Lab Immunol 1988 25 125 129 3260961
56. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. BM Shao W Xu H Dai P Tu Z Li XM Gao, Biochem Biophys Res Commun 2004 320 1103 1111 10.1016/j.bbrc.2004.06.065 15249203 (Pubitemid 38916657)
57. Preliminary observations on the effects of the Chinese medicinal herbs Astragalus membranaceus and Ligustrum lucidum on lymphocyte blastogenic responses. Y Sun EM Hersh SL Lee M McLaughlin TL Loo GM Mavligit, J Biol Response Mod 1983 2 227 237 6644339
58. Fractionated extract of Astragalus membranaceus, a Chinese medicinal herb, potentiates LAK cell cytotoxicity generated by a low dose of recombinant interleukin-2. DT Chu J Lepe-Zuniga WL Wong R LaPushin GM Mavligit, J Clin Lab Immunol 1988 26 183 187 3264344
59. Immunotherapy with Chinese medicinal herbs. I. Immune restoration of local xenogeneic graft-versus-host reaction in cancer patients by fractionated Astragalus membranaceus in vitro. DT Chu WL Wong GM Mavligit, J Clin Lab Immunol 1988 25 119 123 3260960
60. The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. HR Shin JY Kim TK Yun G Morgan H Vainio, Cancer Causes Control 2000 11 565 576 10.1023/A:1008980200583 10880039 (Pubitemid 30342846)
61. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. YS Keum KK Park JM Lee KS Chun JH Park SK Lee H Kwon YJ Surh, Cancer Lett 2000 150 41 48 10.1016/S0304-3835(99)00369-9 10755385 (Pubitemid 30123046)
62. Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Y Jing H Ohizumi N Kawazoe S Hashimoto Y Masuda S Nakajo T Yoshida Y Kuroiwa K Nakaya, Jpn J Cancer Res 1994 85 645 651 8063619
63. Isolation and Structure of Five New Cancer Cell Growth Inhibitory Bufadienolides from the Chinese Traditional Drug Ch'an Su. T Nogawa Y Kamano A Yamashita GR Pettit, J Nat prod 2001 64 1148 1152 10.1021/np0101088 11575946 (Pubitemid 32937882)
64. Mylabris phalerlata induces apoptosis by caspase activation following cytochrome c release and Bid cleavage. JE Huh KS Kang KS Ahn DH Kim I Saiki SH Kim, Life Sci 2003 73 2249 2262 10.1016/S0024-3205(03)00568-X 12927594 (Pubitemid 36962972)
65. Cytotoxic activity of sesquiterpenoids from Atractylodes ovata on leukemia cell lines. CC Wang LG Chen LL Yang, Planta Med 2002 68 204 208 10.1055/s-2002-23144 11914954 (Pubitemid 34270985)
66. Inhibitory effect of bupleuri radix saponins on adhesion of some solid tumor cells and relation to hemolytic action: screening of 232 herbal drugs for anti-cell adhesion. BZ Ahn YD Yoon YH Lee BH Kim DE Sok, Planta Med 1998 64 220 224 10.1055/s-2006-957413 9581518 (Pubitemid 28184008)
67. Immunomodulatory activity of curcumin. S Antony R Kuttan G Kuttan, Immunol Invest 1999 28 291 303 10.3109/08820139909062263 10574627
68. Clinical study of De lisheng injection combined with transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma. XJ Xiang De-bing D Wang G Wang WZ Zhong ZP Li, Modern Oncology 2006 14 7 861 862
69. Clinical study of combination therapy of Jinlong capsule and chemical therapy and embolization by hepatic artery catheterization on primary hepatic carcinoma. CJ Zhang TJ Liang MB Yu, Beijing Medical Journal 2005 27 6 357 359
70. Clinical Observation of Ganfukang capsule combined with TACE in primary liver cancer treatment. LW Cao XC Wang FL Zhang HF Ning YQ Sun LF Yan, Shandong Medical Journal 2005 45 2 13 14
71. Randomized trials published in some Chinese journals: how many are randomized? T Wu Y Li Z Bian G Liu D Moher, Trials 2009 10 46 10.1186/1745-6215-10-46 19573242
72. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. X Shu M McCulloch H Xiao M Broffman J Gao, Integrative cancer therapies 2005 4 219 229 10.1177/1534735405279927 16113029 (Pubitemid 41153748)
73. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. M McCulloch C See XJ Shu M Broffman A Kramer WY Fan J Gao W Lieb K Shieh JM Colford Jr, J Clin Oncol 2006 24 419 430 10.1200/JCO.2005.03.6392 16421421 (Pubitemid 46655594)
74. Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials. M McCulloch M Broffman J Gao JM Colford Jr, American journal of public health 2002 92 1619 1628 10.2105/AJPH.92.10.1619 12356611
75. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis. WC Cho HY Chen, Expert opinion on investigational drugs 2009 18 617 635 10.1517/ 13543780902855308 19388879
76. Artemether for severe malaria: a meta-analysis of randomized clinical trials. MH Pittler E Ernst, Clin Infect Dis 1999 28 597 601 10.1086/515148 10194084
77. Odds ratios should be avoided when events are common. DG Altman JJ Deeks DL Sackett, BMJ (Clinical research ed) 1998 317 1318 9804732
78. Do certain countries produce only positive results? A systematic review of controlled trials. A Vickers N Goyal R Harland R Rees, Controlled clinical trials 1998 19 159 166 10.1016/S0197-2456(97)00150-5 9551280 (Pubitemid 28191970)
79. Chinese authors do need CONSORT: reporting quality for five leading Chinese medical journals. J Li L Xu MM Zhang CL Ai L Wang, Cochrane Colloquium, Freiberg October P80 2008
80. Traditional Chinese medicine. JL Tang BY Liu KW Ma, Lancet 2008 372 1938 1940 10.1016/S0140-6736(08)61354-9 18930523